drugset / Trial / NCT00924222
Organ Protection With Sevoflurane Postconditioning After Cardiac Surgery With Cardiopulmonary Bypass
RandomizedParallel-groupOpen-labelTreatment
Summary
Organ protection, volatile anesthetics, postconditioning. Sedation of patients on ICU after cardiac surgery with cardiopulmonary bypass with either propofol or sevoflurane. Evaluation of organ function and inflammatory mediators in the blood.
Timeline
- Start
- 2007-10
- Primary completion
- 2009-11
- Completion
- 2009-12
Outcome
Met primary endpoint
paper troponin T as the most sensitive marker for myocardial injury at POD1 was significantly lower in the sevoflurane group compared with the propofol group PMID 23062276 ↗
paper unadjusted difference, -0.4; 95% CI, -0.7 to -0.1; P < 0.01 PMID 23062276 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Propofol | Small molecule | — | — |
| Subject | Sevoflurane | Other / unclassified | — | — |
Indications
No indication recorded.